Physical Therapy

Long-Term Monitoring: Staying Ahead of Bone Loss

At a Glance

Long-term monitoring for drug-induced osteoporosis combines repeat DXA bone-density scans, targeted vertebral checks, kidney and calcium testing, safe movement and balance training, and fall prevention. The schedule is tailored to your medicines, age, kidney function, and changing fracture risk.

Living with medication-induced osteoporosis requires a shift from passive treatment to active surveillance. Because you are managing a primary condition while protecting your bones, the goal is to maintain your quality of life and independence by preventing the changes that lead to fractures ^[1]^[2].

Your Individualized Surveillance Schedule

Regular monitoring ensures that your bone-protective plan is actually working. While the exact schedule will depend on your medication, age, and kidney function, a typical surveillance plan includes:

DXA Scan: Often repeated every 1–2 years while on offending meds, tracking changes compared to your baseline ^[3]^[4].
VFA (Vertebral Scan): Not routinely repeated every 1-2 years for everyone, but ordered if you experience height loss, persistent back pain, or other high-risk clinical changes ^[5]^[6].
Kidney Function: Checked before each IV bisphosphonate dose (as these are cleared by the kidneys) and monitored regularly for oral bisphosphonates ^[7].
Calcium Levels: Essential before denosumab doses to prevent severe hypocalcemia (low calcium) ^[7].
Height Check: Should be taken at every office visit. A loss of 0.8 inches (2 cm) in a year is a major indicator to assess your spine ^[5].

Moving Safely: Protecting Your Spine

Staying active is critical, but if your bones are weakened by medications, certain forceful or heavily loaded movements can place excess stress on your vertebrae. Loaded spinal flexion (bending forward and forcefully rounding your back while lifting something heavy) or loaded twisting can increase fracture risk ^[8]^[9].

The “Hip Hinge”: Instead of heavily rounding your back to reach the floor, practice bending at the hips and knees while keeping your back relatively straight ^[10].
Individualized Physical Therapy: There is no universal rule that you must stop all activities. Focus on safe spinal extension and balance training to prevent falls ^[2]^[11]. Work with an osteoporosis-trained physical therapist who can safely progress your resistance and balance exercises without creating unnecessary fear of normal movement ^[2].

Managing the “Scan Anxiety”

It is common to feel a sense of “medical fatigue” or anxiety when treating one disease (like cancer or an autoimmune disorder) while worrying about a side effect like osteoporosis ^[12].

Focus on Trends, Not Just T-Scores: A single scan is just a snapshot. Your doctor looks at the “least significant change”—the amount of change that is statistically meaningful for your specific body—to decide if a treatment is working ^[4].
Continuous Conversation: Your bone health plan is not “set in stone.” If your primary condition improves and you can lower your steroid dose, your fracture risk may also decrease, allowing for adjustments in your monitoring ^[13]^[14]^[15].

Fall-Proofing Your Environment

Since fractures often happen during a fall, your “bone health plan” must include your home environment. Simple changes can significantly reduce your risk:

Remove Trip Hazards: Secure loose rugs with double-sided tape or remove them entirely ^[16].
Improve Lighting: Add nightlights in hallways and bathrooms to prevent stumbles in the dark ^[16].
Supportive Footwear: Wear sturdy, non-slip shoes even when you are inside the house ^[17].
Balance Training: Consider a “Timed Up and Go” assessment with a physical therapist to see if you would benefit from stability exercises ^[11].

Common questions in this guide

How often should I have a DXA scan for drug-induced osteoporosis?

A DXA bone-density scan is often repeated every one to two years while you are taking a medicine that affects your bones. The timing may change based on the medication, your age, kidney function, baseline scan, and how your results are changing, so your clinician should set the schedule.

Does one lower DXA score mean my treatment is failing?

Not necessarily. A single scan is only a snapshot, so your clinician compares it with earlier scans and considers the smallest change that is likely to be real rather than measurement variation. This helps show whether treatment is working over time.

When do I need a vertebral fracture assessment or spine X-ray?

A vertebral fracture assessment is not automatically repeated every one to two years for everyone. Your clinician may order it or a spine X-ray if you lose height, develop persistent or focal back pain, notice posture changes, or have another high-risk change.

Which blood tests are needed before my bone-protective medicine?

Kidney function is checked before each intravenous bisphosphonate dose and monitored regularly when oral bisphosphonates are used. Calcium levels need to be checked before denosumab to reduce the risk of dangerously low calcium, and your clinician will determine the exact testing plan.

What exercise is safe with drug-induced osteoporosis?

There is no universal rule that you must stop all activity, but forceful forward bending with a rounded back and loaded twisting can put extra stress on the spine. A hip-hinge technique, spinal-extension and balance exercises, and guidance from an osteoporosis-trained physical therapist can help you exercise more safely.

How can I make my home safer to prevent fractures?

Remove or secure loose rugs, clear cluttered walkways, add nightlights to dark halls and bathrooms, and wear sturdy nonslip shoes indoors. A physical therapist can also use a Timed Up and Go assessment to see whether balance exercises may help.

Can reducing my steroid dose change my bone-monitoring plan?

If your primary condition improves and your clinician can safely lower your steroid dose, your fracture risk may decrease. Your healthcare team may then adjust how often you need bone scans or other monitoring; do not change the dose on your own.

Get notified when new evidence is published on drug-induced osteoporosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

DXA bone-density scans are often repeated every one to two years during treatment, but the schedule depends on the medication, age, kidney function, and changes from baseline.
A single bone-density score is only a snapshot; clinicians compare scans over time and look for a change that is large enough to be meaningful.
Vertebral fracture assessment or spine imaging is considered when height decreases, posture changes, or persistent or focal back pain develops rather than being repeated routinely for everyone.
Kidney function should be checked before intravenous bisphosphonate doses, while calcium should be checked before denosumab doses and kidney function monitored with oral bisphosphonates.
Safer movement, osteoporosis-focused physical therapy, and home fall-proofing can reduce fracture risk while avoiding loaded spinal bending and twisting.

References (17)

1
Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update.
Morin SN, Feldman S, Funnell L, et al.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2023; (195(39)):E1333-E1348 doi:10.1503/cmaj.221647.
PMID: 37816527
2
Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis.
Brooke-Wavell K, Skelton DA, Barker KL, et al.
British journal of sports medicine 2022; (56(15)):837-846 doi:10.1136/bjsports-2021-104634.
PMID: 35577538
3
Bone health in patients with cancer: a SEOM-SEIOMM consensus review of risk factors, assessment strategies, and management approaches.
Beato-Zambrano C, Nogues X, Ramírez-Merino N, et al.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; (28(8)):3059-3074 doi:10.1007/s12094-026-04256-1.
PMID: 41703396
4
Repeating Measurement of Bone Mineral Density when Monitoring with Dual-energy X-ray Absorptiometry: 2019 ISCD Official Position.
Kendler DL, Compston J, Carey JJ, et al.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2019; (22(4)):489-500 doi:10.1016/j.jocd.2019.07.010.
PMID: 31378452
5
Repeating Vertebral Fracture Assessment: 2019 ISCD Official Position.
Borges JLC, Sousa da Silva M, Ward RJ, et al.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2019; (22(4)):484-488 doi:10.1016/j.jocd.2019.07.005.
PMID: 31375350
6
Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best Practices.
Lems WF, Ward KA, Lewiecki EM, et al.
Mayo Clinic proceedings 2025; (100(12)):2186-2205 doi:10.1016/j.mayocp.2025.08.005.
PMID: 41338753
7
Safety of In-hospital Parenteral Antiosteoporosis Therapy Following a Hip Fracture: A Retrospective Cohort.
Abu-Jwead A, Fisher DL, Goldabart A, et al.
Journal of the Endocrine Society 2024; (8(11)):bvae172 doi:10.1210/jendso/bvae172.
PMID: 39416429
8
Pathogenesis of Vertebral Anterior Wedge Deformity: A 2-Stage Process?
Landham PR, Gilbert SJ, Baker-Rand HL, et al.
Spine 2015; (40(12)):902-8 doi:10.1097/BRS.0000000000000905.
PMID: 25822544
9
Patterns of Load-to-Strength Ratios Along the Spine in a Population-Based Cohort to Evaluate the Contribution of Spinal Loading to Vertebral Fractures.
Mokhtarzadeh H, Anderson DE, Allaire BT, Bouxsein ML
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2021; (36(4)):704-711 doi:10.1002/jbmr.4222.
PMID: 33253414
10
The Vertebral Fracture Cascade: Etiology and Clinical Implications.
Broy SB
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2016; (19(1)):29-34.
PMID: 26363627
11
Effects of resistance and balance exercises for athletic ability and quality of life in people with osteoporotic vertebral fracture: Systematic review and meta-analysis of randomized control trials.
Li X, Chen W, Chen Q, et al.
Frontiers in medicine 2023; (10()):1135063 doi:10.3389/fmed.2023.1135063.
PMID: 36968833
12
Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.
Stanghelle B, Bentzen H, Giangregorio L, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2020; (31(6)):1069-1078 doi:10.1007/s00198-019-05256-4.
PMID: 31925473
13
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis.
Park SY, Gong HS, Kim KM, et al.
Journal of bone metabolism 2018; (25(4)):195-211 doi:10.11005/jbm.2018.25.4.195.
PMID: 30574464
14
Bone Mineral Density: Clinical Relevance and Quantitative Assessment.
Haseltine KN, Chukir T, Smith PJ, et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(4)):446-454 doi:10.2967/jnumed.120.256180.
PMID: 33310738
15
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
Laurent MR, Goemaere S, Verroken C, et al.
Frontiers in endocrinology 2022; (13()):908727 doi:10.3389/fendo.2022.908727.
PMID: 35757436
16
Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society.
Paccou J, Yavropoulou MP, Naciu AM, et al.
European journal of endocrinology 2024; (191(6)):G1-G17 doi:10.1093/ejendo/lvae146.
PMID: 39556468
17
Screening for Geriatric Syndromes: Falls, Urinary/Fecal Incontinence, and Osteoporosis.
Smith EM, Shah AA
Clinics in geriatric medicine 2018; (34(1)):55-67 doi:10.1016/j.cger.2017.08.002.
PMID: 29129217

This page explains long-term monitoring for drug-induced osteoporosis for educational purposes and does not replace medical advice. Ask your healthcare team before changing medication or exercise, especially if you have back pain or kidney or calcium concerns.